T. Rowe Price Associates
OCGN icon

T. Rowe Price Associates’s Ocugen OCGN Stock Holding History

T. Rowe Price Associates’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430K Buy
+280,639
New +$427K ﹤0.01% 2687
2025
Q2 		– Sell
-123,718
Closed -$88K – 3123
2025
Q1 		$88K Buy
123,718
+10,646
+9% +$7.36K ﹤0.01% 2848
2024
Q4 		$91K Sell
113,072
-122,788
-52% -$112K ﹤0.01% 2846
2024
Q3 		$235K Sell
235,860
-32,960
-12% -$45.2K ﹤0.01% 2590
2024
Q2 		$417K Buy
268,820
+81,720
+44% +$127K ﹤0.01% 2264
2024
Q1 		$307K Hold
187,100
– – ﹤0.01% 2422
2023
Q4 		$108K Buy
187,100
+93,000
+99% +$37.3K ﹤0.01% 2708
2023
Q3 		$38K Buy
94,100
+62,800
+201% +$31K ﹤0.01% 2805
2023
Q2 		$17K Sell
31,300
-137,003
-81% -$87.8K ﹤0.01% 2868
2023
Q1 		$144K Buy
168,303
+4,571
+3% +$4.98K ﹤0.01% 2609
2022
Q4 		$213K Buy
163,732
+26,910
+20% +$41.9K ﹤0.01% 2503
2022
Q3 		$244K Buy
136,822
+12,800
+10% +$31.9K ﹤0.01% 2470
2022
Q2 		$282K Sell
124,022
-6,220
-5% -$14.9K ﹤0.01% 2471
2022
Q1 		$430K Buy
130,242
+2,609
+2% +$9.17K ﹤0.01% 2405
2021
Q4 		$581K Buy
127,633
+21,576
+20% +$163K ﹤0.01% 2315
2021
Q3 		$761K Buy
106,057
+65,800
+163% +$483K ﹤0.01% 2183
2021
Q2 		$323K Buy
40,257
+27,957
+227% +$236K ﹤0.01% 2571
2021
Q1 		$84K Buy
+12,300
New +$81.8K ﹤0.01% 2792

Other funds holding OCGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

T. Rowe Price Associates's OCGN Position: Q2 2026 in Review

T. Rowe Price Associates opened a new position in Ocugen (OCGN) in Q2 2026: 280,639 shares worth $430K. The stake represents ﹤0.01% of the portfolio and ranks #2687 among its holdings. This is a return to the name: T. Rowe Price Associates previously reported a position in OCGN as recently as Q1 2025.

T. Rowe Price Associates first reported a position in OCGN in Q1 2021 and has held it in 18 quarters since. The position peaked at $761K in Q3 2021. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • T. Rowe Price Associates held 280,639 shares of Ocugen worth $430K as of Q2 2026.
  • Ocugen was a new T. Rowe Price Associates position in Q2 2026.
  • Ocugen made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2687 holding.
  • T. Rowe Price Associates first reported a position in Ocugen in Q1 2021 and has held it in 18 quarters since.
  • T. Rowe Price Associates's Ocugen position peaked at $761K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.